Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 7.96% |
| 10 | Standard Biotools | 254.39 Mn | -222.33 Mn | 10.54 Mn | -14.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.55% |
| Mar 31, 2026 | -11.89% |
| Dec 31, 2025 | -9.09% |
| Sep 30, 2025 | -7.94% |
| Jun 30, 2025 | -5.97% |
| Mar 31, 2025 | 16.32% |
| Dec 31, 2024 | -6.69% |
| Sep 30, 2024 | 13.24% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 23.49% |
| Dec 31, 2023 | 11.32% |
| Sep 30, 2023 | 48.25% |
| Jun 30, 2023 | 46.09% |
| Mar 31, 2023 | 45.34% |
| Dec 31, 2022 | 47.12% |
| Sep 30, 2022 | 46.84% |
| Jun 30, 2022 | 48.68% |
| Mar 31, 2022 | 49.84% |
| Dec 31, 2021 | 47.00% |
| Sep 30, 2021 | 43.62% |